Drugs in development.
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003497:Cyclic N-Oxides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009570:Nitriles; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000494:pharmacology / Q000627:therapeutic use; D010091:Oximes; D010880:Piperidines; D011724:Pyridazines; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines; D000068698:Tenofovir
D019380:Anti-HIV Agents; D003497:Cyclic N-Oxides; D009570:Nitriles; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D010091:Oximes; D010880:Piperidines; D011724:Pyridazines; D011725:Pyridines; D011743:Pyrimidines; C451734:etravirine; C438583:Ancriviroc; D000068698:Tenofovir; D000225:Adenine